Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Legend hires Koneru as CMO

Plus: Erasca promotes Morris, Lovejoy and updates from Poseida, Mithra, Tune, Cellarity and more

April 11, 2023 11:24 PM UTC

Cell therapy company  Legend Biotech Corp. (NASDAQ:LEGN) hired Mythili Koneru as CMO. Koneru was CMO at Marker Therapeutics Inc. (NASDAQ:MRKR) and associate VP of immuno-oncology at Eli Lilly and Co. (NYSE:LLY).

Cancer company Erasca Inc. (NASDAQ:ERAS) promoted Shannon Morris to CMO from SVP of clinical development, and Chandra Lovejoy to chief regulatory affairs officer from SVP of regulatory affairs. Morris, who succeeds CMO Wei Lin, joined Erasca in 2022 from Istari Oncology Inc.; Lovejoy joined in 2021 from G1 Therapeutics Inc. (NASDAQ:GTHX). Lin is stepping down to pursue other opportunities. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article